Zipeprol

Zipeprol

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	R05DB15 (WHO)
Legal status
Legal status	US: Schedule I Schedule II international
Identifiers
IUPAC name 1-methoxy- 3-[4-(2-methoxy- 2-phenylethyl)piperazin- 1-yl]- 1-phenylpropan- 2-ol
CAS Number	34758-83-3 N
PubChem CID	36910
ChemSpider	33868 Y
UNII	G5MUV8139H
KEGG	D07390 Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C23H32N2O3
Molar mass	384.512 g/mol
3D model (JSmol)	Interactive image
SMILES OC(CN1CCN(CC1)CC(OC)c2ccccc2)C(OC)c3ccccc3
InChI InChI=1S/C23H32N2O3/c1-27-22(19-9-5-3-6-10-19)18-25-15-13-24(14-16-25)17-21(26)23(28-2)20-11-7-4-8-12-20/h3-12,21-23,26H,13-18H2,1-2H3 Y Key:VSTNNAYSCJQCQI-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

WikiDoc Resources for Zipeprol
Articles
Most recent articles on Zipeprol Most cited articles on Zipeprol Review articles on Zipeprol Articles on Zipeprol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Zipeprol Images of Zipeprol Photos of Zipeprol Podcasts & MP3s on Zipeprol Videos on Zipeprol
Evidence Based Medicine
Cochrane Collaboration on Zipeprol Bandolier on Zipeprol TRIP on Zipeprol
Clinical Trials
Ongoing Trials on Zipeprol at Clinical Trials.gov Trial results on Zipeprol Clinical Trials on Zipeprol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Zipeprol NICE Guidance on Zipeprol NHS PRODIGY Guidance FDA on Zipeprol CDC on Zipeprol
Books
Books on Zipeprol
News
Zipeprol in the news Be alerted to news on Zipeprol News trends on Zipeprol
Commentary
Blogs on Zipeprol
Definitions
Definitions of Zipeprol
Patient Resources / Community
Patient resources on Zipeprol Discussion groups on Zipeprol Patient Handouts on Zipeprol Directions to Hospitals Treating Zipeprol Risk calculators and risk factors for Zipeprol
Healthcare Provider Resources
Symptoms of Zipeprol Causes & Risk Factors for Zipeprol Diagnostic studies for Zipeprol Treatment of Zipeprol
Continuing Medical Education (CME)
CME Programs on Zipeprol
International
Zipeprol en Espanol Zipeprol en Francais
Business
Zipeprol in the Marketplace Patents on Zipeprol
Experimental / Informatics
List of terms related to Zipeprol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Zipeprol is a centrally acting cough suppressant developed in France in the 1970s. It is not an morphinan derivative (in contrast to codeine and dextromethorphan). Zipeprol acts as a local anaesthetic and has mucolytic, antihistamine and anticholinergic properties.It is sold with several brand names such as Zinolta and Respilene. It is not available in the United States or Canada and has been discontinued in Europe. It is still available in some countries in Asia and South America.

Zipeprol has been misused in Korea, mainly for the hallucinations it produces. Such use has become an issue due to the seizures and various neurological side effects it causes at high dosages.

References

Template:Cough and cold preparations